Vortex Imaging is developing a compact ultrasound-based imaging system that uses pioneering computational image reconstruction technology and GPUs-on-Cloud to produce high-quality 3D volumetric images. The system is designed to provide volumetric visualization traditionally associated with CT and MRI while retaining ultrasound's portability, safety, and lack of ionizing radiation. Vortex aims to reduce operator dependency and produce standardized, reproducible volumetric datasets with a reduced learning curve. Its initial clinical focus is on urology and nephrology, with plans to expand into additional diagnostic and procedural domains. The company is pursuing FDA clearance and preparing for initial clinical deployment and commercialization. The press release lists operations in Sunnyvale, Calif. and Givatayim, Israel and notes recent board additions to support commercialization.

Total raised

$12M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026